Cargando…
Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections
Helicobacter pylori (H. pylori) is the main cause of gastric diseases. However, the traditional antibiotic treatment of H. pylori is limited due to increased antibiotic resistance, low efficacy, and low drug concentration in the stomach. This study developed a Nano-emulsion system with ability to ca...
Autores principales: | Mosallam, Farag M., Bendary, Mahmoud M., Elshimy, Rana, El-Batal, Ahmed I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541836/ https://www.ncbi.nlm.nih.gov/pubmed/37773301 http://dx.doi.org/10.1007/s11274-023-03745-7 |
Ejemplares similares
-
Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020) -
Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021) -
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023) -
Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains
por: Binh, Tran Thanh, et al.
Publicado: (2013) -
A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori
por: Tadjrobehkar, Omid, et al.
Publicado: (2014)